Literature DB >> 11353723

Delayed onset and resolution of pain: some observations and implications.

G D Schott1.   

Abstract

Occasionally, pain after disease or trauma develops only after a prolonged interval. Examples include late-onset pains which first occur months or years following a stroke, spinal cord lesion or amputation of a limb; a previously experienced pain that is recalled years later; and latent pain triggered for the first time by a further insult in the same area. Late-onset pains may develop gradually or suddenly, and may be brief or long standing. Pains which develop after an innocuous insult may be associated with slowly evolving sensory changes. However, even long-standing pains, particularly those of nociceptive origin, may resolve sometimes after many years. Resolution, which again can occur gradually or suddenly, may be spontaneous or follow development of another disorder or after therapeutic intervention. The duration of this pain relief can range from minutes to an indefinite period. These clinical phenomena, and the mechanisms, including genetic factors, subserving them, have been little studied. It is postulated that mechanisms implicated in acute pain may not be the same as those that subserve pain that develops after a long interval. Those late-onset pains which develop slowly after innocuous lesions may be associated with a variety of slow anatomical, physiological and biochemical changes. In late-onset pains that follow a painful insult, however, memory of the former pain and threshold triggering factors may be particularly important. Further studies of these neglected conditions may lead to understanding of as yet unknown processes subserving pain and to novel approaches to treatment.

Entities:  

Mesh:

Year:  2001        PMID: 11353723     DOI: 10.1093/brain/124.6.1067

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  11 in total

Review 1.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

2.  Pain after stroke: a neglected issue.

Authors:  H Hénon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05       Impact factor: 10.154

Review 3.  Surgically induced neuropathic pain: understanding the perioperative process.

Authors:  David Borsook; Barry D Kussman; Edward George; Lino R Becerra; Dennis W Burke
Journal:  Ann Surg       Date:  2013-03       Impact factor: 12.969

Review 4.  Management of persistent postsurgical inguinal pain.

Authors:  Mads U Werner
Journal:  Langenbecks Arch Surg       Date:  2014-05-23       Impact factor: 3.445

5.  Capsaicin avoidance as a measure of chemical hyperalgesia in orofacial nerve injury models.

Authors:  Yves Boucher; Mirela Iodi Carstens; Carolyn M Sawyer; Karen L Zanotto; Austin W Merrill; E Carstens
Journal:  Neurosci Lett       Date:  2013-04-02       Impact factor: 3.046

6.  Potential for Cell-Transplant Therapy with Human Neuronal Precursors to Treat Neuropathic Pain in Models of PNS and CNS Injury: Comparison of hNT2.17 and hNT2.19 Cell Lines.

Authors:  Mary J Eaton; Yerko Berrocal; Stacey Q Wolfe
Journal:  Pain Res Treat       Date:  2012-04-24

Review 7.  Ocular neuropathic pain.

Authors:  Perry Rosenthal; David Borsook
Journal:  Br J Ophthalmol       Date:  2015-05-05       Impact factor: 4.638

8.  The refined biomimetic NeuroDigm GEL™ model of neuropathic pain in a mature rat.

Authors:  Mary R Hannaman; Douglas A Fitts; Rose M Doss; David E Weinstein; Joseph L Bryant
Journal:  F1000Res       Date:  2016-10-13

9.  Implementing a Pain Assessment Survey and Team Approach Method to Effectively Assess and Treat Pain in Poststroke Patients.

Authors:  Kirill Alekseyev; Peter Iskander; Patrick De Santo
Journal:  Arch Rehabil Res Clin Transl       Date:  2020-05-11

Review 10.  Subliminal (latent) processing of pain and its evolution to conscious awareness.

Authors:  David Borsook; Andrew M Youssef; Nadia Barakat; Christine B Sieberg; Igor Elman
Journal:  Neurosci Biobehav Rev       Date:  2018-02-21       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.